Stockreport

Milestone Pharmaceuticals: Cardamyst Beat Placebo, But The Commercial Bar Is Higher [Seeking Alpha]

Milestone Pharmaceuticals Inc. - Common Shares  (MIST) 
Last milestone pharmaceuticals inc. - common shares earnings: 3/6 07:00 am Check Earnings Report
PDF The PSVT market is crowded with effective, cheap oral generics and ablation, making MIST's premium pricing and differentiation difficult to justify. RAPID trial data [Read more]